Delivery Order SPE2DB24D2205-SPE2DB25FEDWM
- Not listed
- The Defense Logistics Agency awarded a $8,838.28 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml quantities. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by December 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $8,586.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed out of the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,033.40 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger vehicle within DLA's pharmaceutical procurement...
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $6,602.38 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with an ultimate completion date of August 18, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen's place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters....
- The Defense Logistics Agency has awarded a delivery order valued at $37,827.70 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed price contract involves no set-aside designation and carries an ultimate completion date of November 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $12,426.16 and a completion date of November 18, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $35,895.83 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,376.77 by the Defense Logistics Agency on December 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of December 30, 2025, and was awarded on a competitive basis without set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,633.25 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract utilizes a firm fixed price arrangement with an ultimate completion date of August 8, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDWMDelivery Order
The Defense Logistics Agency awarded a $17,750.60 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major healthcare solutions provider and pharmaceutical distributor. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 6/18/25 |